{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.58 vs. cons $3.46",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net revenue",
      "prediction": "BEAT",
      "answer": "pred ~$737M vs. cons $714M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total options RPC",
      "prediction": "IN-LINE",
      "answer": "pred ~$0.319 vs. cons $0.317",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic total net-revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~14% midpoint (low-double-digit to mid-teens) vs. cons 14% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating expense",
      "prediction": "UNCHANGED",
      "answer": "guide ~$846M midpoint ($838M-$853M) vs. cons $846M (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Data Vantage organic net-revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~10% (low-double-digit) vs. cons 10% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.8,
  "day5_path": "STABILIZE",
  "day5_rationale": "A ~$3.58 EPS versus $3.46 consensus beat and ~$737M revenue versus $714M should support an initially positive response, but a ~$0.319 options RPC versus $0.317 and unchanged FY2026 organic-growth and opex guide leave limited out-period estimate upside. The initial gain should stabilize rather than extend materially as revisions remain modest.",
  "day5_confidence": "MEDIUM"
}